Leslie E. Huye

2.1k total citations
28 papers, 1.7k citations indexed

About

Leslie E. Huye is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Leslie E. Huye has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Leslie E. Huye's work include CAR-T cell therapy research (12 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (7 papers). Leslie E. Huye is often cited by papers focused on CAR-T cell therapy research (12 papers), Virus-based gene therapy research (7 papers) and Immune Cell Function and Interaction (7 papers). Leslie E. Huye collaborates with scholars based in United States, Germany and United Kingdom. Leslie E. Huye's co-authors include Shunbin Ning, Joseph S. Pagano, Cliona M. Rooney, Gianpietro Dotti, Malcolm K. Brenner, David B. Roth, Helen E. Heslop, Barbara Savoldo, Matthew H. Wilson and Yozo Nakazawa and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Blood.

In The Last Decade

Leslie E. Huye

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie E. Huye United States 19 1.0k 663 615 425 280 28 1.7k
Michael Klichinsky United States 14 1.3k 1.3× 902 1.4× 586 1.0× 327 0.8× 145 0.5× 56 2.0k
Franziska Blaeschke Germany 18 832 0.8× 449 0.7× 658 1.1× 288 0.7× 163 0.6× 33 1.4k
Alanna Ruddell United States 20 846 0.8× 602 0.9× 825 1.3× 159 0.4× 155 0.6× 43 1.8k
Carsten Linnemann Netherlands 17 1.7k 1.7× 1.8k 2.7× 736 1.2× 316 0.7× 112 0.4× 21 2.5k
Anna Morena D’Alise Italy 19 464 0.5× 592 0.9× 866 1.4× 349 0.8× 134 0.5× 42 1.7k
Blythe Sather United States 19 733 0.7× 1.1k 1.7× 671 1.1× 442 1.0× 148 0.5× 29 2.0k
Patrick A. Oberholzer Switzerland 18 768 0.8× 467 0.7× 887 1.4× 228 0.5× 239 0.9× 26 1.8k
Roy Lau United States 20 957 0.9× 1.3k 2.0× 727 1.2× 406 1.0× 111 0.4× 33 2.0k
Xue F. Huang United States 20 587 0.6× 781 1.2× 710 1.2× 289 0.7× 105 0.4× 34 1.6k
Uwe Reusch Germany 26 813 0.8× 1.2k 1.8× 689 1.1× 78 0.2× 387 1.4× 72 2.2k

Countries citing papers authored by Leslie E. Huye

Since Specialization
Citations

This map shows the geographic impact of Leslie E. Huye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie E. Huye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie E. Huye more than expected).

Fields of papers citing papers by Leslie E. Huye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie E. Huye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie E. Huye. The network helps show where Leslie E. Huye may publish in the future.

Co-authorship network of co-authors of Leslie E. Huye

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie E. Huye. A scholar is included among the top collaborators of Leslie E. Huye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie E. Huye. Leslie E. Huye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Galvan, Daniel L., Richard T. O’Neil, Aaron E. Foster, et al.. (2015). Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model. PLoS ONE. 10(10). e0140744–e0140744. 8 indexed citations
3.
Perna, Serena, et al.. (2015). Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy. ImmunoTargets and Therapy. 4. 55–55. 2 indexed citations
4.
Byrd, Tiara T., et al.. (2015). Polystyrene microspheres enable 10‐color compensation for immunophenotyping of primary human leukocytes. Cytometry Part A. 87(11). 1038–1046. 9 indexed citations
5.
Nakazawa, Yozo, Daniel L. Galvan, Leslie E. Huye, et al.. (2012). Evaluation of Long-term Transgene Expression in piggyBac-Modified Human T Lymphocytes. Journal of Immunotherapy. 36(1). 3–10. 21 indexed citations
6.
Nakazawa, Yozo, et al.. (2012). <em>piggyBac</em> Transposon System Modification of Primary Human T Cells. Journal of Visualized Experiments. e4235–e4235. 14 indexed citations
7.
Gerdemann, Ulrike, Jacqueline M. Keirnan, Usha L. Katari, et al.. (2012). Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections. Molecular Therapy. 20(8). 1622–1632. 188 indexed citations
8.
Huye, Leslie E., Yozo Nakazawa, Mayuri Patel, et al.. (2011). Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination. Molecular Therapy. 19(12). 2239–2248. 39 indexed citations
9.
Huye, Leslie E., et al.. (2011). Hyperactive piggyBac Gene Transfer in Human Cells and In Vivo. Human Gene Therapy. 23(3). 311–320. 79 indexed citations
10.
Nakazawa, Yozo, Leslie E. Huye, Vita S. Salsman, et al.. (2011). PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor. Molecular Therapy. 19(12). 2133–2143. 103 indexed citations
11.
Sun, Jiali, Gianpietro Dotti, Leslie E. Huye, et al.. (2010). T Cells Expressing Constitutively Active Akt Resist Multiple Tumor-associated Inhibitory Mechanisms. Molecular Therapy. 18(11). 2006–2017. 61 indexed citations
12.
Huye, Leslie E., Barbara Savoldo, Gianpietro Dotti, Matthew H. Wilson, & Cliona M. Rooney. (2010). Combining Mtor Inhibitors with Rapa-Resistant T Cells: a Two-Pronged Approach to Tumor Elimination. Blood. 116(21). 2853–2853. 1 indexed citations
13.
Nakazawa, Yozo, Leslie E. Huye, Gianpietro Dotti, et al.. (2009). Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes. Journal of Immunotherapy. 32(8). 826–836. 92 indexed citations
14.
Angelis, Biagio De, Gianpietro Dotti, Concetta Quintarelli, et al.. (2009). Generation Of Virus-Specific Cytotoxic T Lymphocytes (CTLS) Resistant to the Immunosuppressive Drug Tacrolimus (FK506). Biology of Blood and Marrow Transplantation. 15(2). 135–135. 1 indexed citations
15.
Huye, Leslie E., Shunbin Ning, Michelle A. Kelliher, & Joseph S. Pagano. (2007). Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination. Molecular and Cellular Biology. 27(8). 2910–2918. 71 indexed citations
16.
Ning, Shunbin, Leslie E. Huye, & Joseph S. Pagano. (2005). Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling. Journal of Biological Chemistry. 280(13). 12262–12270. 79 indexed citations
17.
Ning, Shunbin, Leslie E. Huye, & Joseph S. Pagano. (2005). Interferon Regulatory Factor 5 Represses Expression of the Epstein-Barr Virus Oncoprotein LMP1: Braking of the IRF7/LMP1 Regulatory Circuit. Journal of Virology. 79(18). 11671–11676. 41 indexed citations
18.
Zhang, Zhixin, Michael Zemlin, Yui‐Hsi Wang, et al.. (2003). Contribution of VH Gene Replacement to the Primary B Cell Repertoire. Immunity. 19(1). 21–31. 86 indexed citations
19.
Neiditch, Matthew B., Gregory S. Lee, Leslie E. Huye, Vicky Brandt, & David B. Roth. (2002). The V(D)J Recombinase Efficiently Cleaves and Transposes Signal Joints. Molecular Cell. 9(4). 871–878. 36 indexed citations
20.
Sikes, Michael L., Ruth Sullivan, Leslie E. Huye, et al.. (2002). Cancer predisposition and hematopoietic failure in Rad50 S/S mice. Genes & Development. 16(17). 2237–2251. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Klichinsky Breakdown of academic impact, for papers by Franziska Blaeschke Breakdown of academic impact, for papers by Alanna Ruddell Breakdown of academic impact, for papers by Carsten Linnemann Breakdown of academic impact, for papers by Anna Morena D’Alise Breakdown of academic impact, for papers by Blythe Sather Breakdown of academic impact, for papers by Patrick A. Oberholzer Breakdown of academic impact, for papers by Roy Lau Breakdown of academic impact, for papers by Xue F. Huang Breakdown of academic impact, for papers by Uwe Reusch
Rankless by CCL
2026